Used as a key intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure supports selective binding to enzyme targets due to the fluoropyridine moiety, enhancing metabolic stability and bioavailability. Commonly employed in medicinal chemistry for constructing complex molecules with improved pharmacokinetic profiles. Also utilized in research settings to explore structure-activity relationships in drug discovery programs targeting neurological and oncological diseases.